About Us
Our Partnership
Key Structures
Engage With Us
Topics
Replenishment
Our Financing
Results & Data
Impact Stories
The “Pink Girls” of Zambia: Breaking Down HIV Silence and Stigma
An Invisible Line of Defense: How Laboratory Workers in Asia-Pacific Protect Against the Next Pandemic
Global Health Security
A Decade of Progress: Halting Drug-Resistant Malaria in Southeast Asia
Media Resources
News Releases
Opinion
Publication Categories
Resources
Approved by the Board on: 31 October 2011
The Board decides to amend the upper ceiling amounts for the three Round 10 consolidated proposals listed below:
Country/ Disease Component | Amended Phase 1 Upper ceiling (2 years)(US$) | Amended Lifetime Upper ceiling (Up to 5 Years) (US$) |
Bangladesh/TB | 16,363,126 | 105,724,068 |
Mongolia/TB, including cross-cutting HSS | 5,763,691 | 9,124,194 |
Swaziland/TB | 12,864,643 | 39,709,609 |
The Board approves the amended upper ceiling amounts specified above for the initial two years.
This decision does not have material budgetary implications for the 2011 Operating Expenses Budget.